Publication | Open Access
Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia
41
Citations
37
References
2013
Year
Collectively, these data support the diagnostic utility of CD335 in evaluating hematopoietic malignancies and suggest that CD335 could be a useful target for selective immunotherapy in patients with mature NK and T-cell neoplasms.
| Year | Citations | |
|---|---|---|
Page 1
Page 1